What's next at End­points: a big­ger, more am­bi­tious news­room

I’ve had a lit­tle over a month in the Ex­ec­u­tive Ed­i­tor seat here at End­points News, and I want to take a mo­ment to in­tro­duce my­self to this great com­mu­ni­ty of read­ers and talk about where we’re head­ed next.

For the last 20 years, I’ve been lucky to cov­er some of the biggest sto­ries in health­care. I had a front-row seat on Capi­tol Hill for the Af­ford­able Care Act, wrote the first sto­ries about our cur­rent drug price de­bate, and spent three years lead­ing projects on the Covid-19 pan­dem­ic. Dur­ing that time, we’ve wit­nessed amaz­ing ad­vances in the treat­ment of can­cer, the ma­nip­u­la­tion of ge­net­ics and our un­der­stand­ing of hu­man bi­ol­o­gy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER